[Skip to Content]
[Skip to Content Landing]
Views 1,624
Citations 0
Research Letter
June 26, 2019

Assessment of Strategies for Managing Expansion of Diagnosis Coding Using Risk-Adjustment Methods for Medicare Data

Author Affiliations
  • 1Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA (University of California, Los Angeles)
  • 2Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  • 3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
  • 4Department of Health Policy, London School of Economics and Political Science, London, England
  • 5Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  • 6Veterans Affairs Healthcare System, Boston, Massachusetts
JAMA Intern Med. Published online June 26, 2019. doi:10.1001/jamainternmed.2019.1005

Since the passage of the Affordable Care Act (ACA) in 2010, many studies have used national Medicare data to examine associations between national hospital pay-for-performance programs and quality and costs of care.1-4 In January 2011, as the ACA was being implemented, the Centers for Medicare & Medicaid Services increased the number of available diagnosis billing codes from a maximum of 9 diagnosis codes (the primary diagnosis plus 8 comorbidities; a tenth code was reserved for coding external causes of injury and usually left blank5) to 25 diagnosis codes (the primary diagnosis plus 24 comorbidities).

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words